{"count": 2, "results": [{"_id": "6112564", "pmid": 6112564, "title": "Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome.", "journal": "Lancet", "authors": ["Telford AM", "Wilson C"], "date": "1981-06-06T00:00:00Z", "doi": "10.1016/s0140-6736(81)92399-0", "meta_date_publication": "1981 Jun 6", "meta_volume": "1", "meta_issue": "8232", "meta_pages": "1225-8", "score": 50066.805, "text_hl": "Trial of @CHEMICAL_Heparin @CHEMICAL_MESH:D006493 @@@heparin@@@ versus @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ in prevention of @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@myocardial infarction@@@ in intermediate @<m>DISEASE_Acute_Coronary_Syndrome</m> @DISEASE_MESH:D054058 @@@coronary syndrome@@@.", "citations": {"NLM": "Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome. Lancet. 1981 Jun 6;1(8232):1225-8. PMID: 6112564", "BibTeX": "@article{6112564, title={Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome.}, author={Telford AM and Wilson C}, journal={Lancet}, volume={1}, number={8232}, pages={1225-8}}"}}, {"_id": "17664990", "pmid": 17664990, "title": "Influence of cardiopulmonary bypass on the plasma concentrations of atenolol.", "journal": "Arq Bras Cardiol", "authors": ["Leite Fda S", "dos Santos LM", "Bonafé WW", "Chignalia AZ", "Carmona MJ", "Suyama MJ", "Malbouisson LM", "Auler JO Jr", "Santos SR"], "date": "2007-06-01T00:00:00Z", "doi": "10.1590/s0066-782x2007000600003", "meta_date_publication": "2007 Jun", "meta_volume": "88", "meta_issue": "6", "meta_pages": "637-42", "score": 50066.598, "text_hl": "CONCLUSION: In view of its cardio-selectivity and low-variability, @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ should be used as the first-choice drug for the treatment of @<m>DISEASE_Acute_Coronary_Syndrome</m> @DISEASE_MESH:D054058 @@@acute coronary syndrome@@@ and other @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular diseases@@@.", "citations": {"NLM": "Leite Fda S, dos Santos LM, Bonafé WW, Chignalia AZ, Carmona MJ, Suyama MJ, Malbouisson LM, Auler JO Jr, Santos SR. Influence of cardiopulmonary bypass on the plasma concentrations of atenolol. Arq Bras Cardiol. 2007 Jun;88(6):637-42. PMID: 17664990", "BibTeX": "@article{17664990, title={Influence of cardiopulmonary bypass on the plasma concentrations of atenolol.}, author={Leite Fda S and dos Santos LM and Bonafé WW and Chignalia AZ and Carmona MJ and Suyama MJ and Malbouisson LM and Auler JO Jr and Santos SR}, journal={Arq Bras Cardiol}, volume={88}, number={6}, pages={637-42}}"}}]}